Financhill
Sell
34

VRCA Quote, Financials, Valuation and Earnings

Last price:
$0.56
Seasonality move :
-18.32%
Day range:
$0.47 - $0.55
52-week range:
$0.38 - $11.41
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.77x
P/B ratio:
192.69x
Volume:
460.6K
Avg. volume:
346.6K
1-year change:
-94.36%
Market cap:
$50.9M
Revenue:
$7.6M
EPS (TTM):
-$1.54

Earnings Data

Next earnings date for VRCA
Aug 14
2025
Most recent earnings per share
-$0.24
Beat by $0.00
(Mar 11/2025)
Consensus Estimate
-$0.24
(Mar 11/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

VRCA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/14/2025 Q2 $4.3M -- -- -$0.13 --
05/13/2025 Q1 $2.5M -- -- -$0.14 --
03/11/2025 Q4 $1.3M $344K -$0.24 -$0.24 $0.00
11/04/2024 Q3 $5.3M -$1.8M -$0.49 -$0.39 -$0.10
08/14/2024 Q2 $4.5M $5.2M -$0.37 -$0.40 $0.03
05/13/2024 Q1 $2.7M $3.8M -$0.44 -$0.44 --
02/29/2024 Q4 $948K $2M -$0.54 -$0.56 $0.02
11/09/2023 Q3 -- -- -$0.54 -$0.39 -$0.15
08/08/2023 Q2 -- -- -$0.24 -$0.20 -$0.04
05/09/2023 Q1 -- -- -$0.15 -$0.17 $0.02
03/06/2023 Q4 -- -- -$0.14 -$0.19 $0.05
11/07/2022 Q3 -- -- $0.00 -$0.10 $0.10
08/11/2022 Q2 -- -- -$0.37 -$0.32 -$0.05
05/09/2022 Q1 -- -- -$0.31 -$0.45 $0.14
03/02/2022 Q4 -- -- -$0.35 -$0.48 $0.13
11/12/2021 Q3 -- -- -$0.47 -$0.51 $0.04
08/10/2021 Q2 -- -- -$0.43 -$0.41 -$0.02
05/07/2021 Q1 -- -- -$0.04 -$0.34 $0.30
03/04/2021 Q4 -- -- -$0.52 -$0.41 -$0.11
11/09/2020 Q3 -- -- -$0.42 -$0.43 $0.01
08/05/2020 Q2 -- -- -$0.38 -$0.44 $0.06
05/07/2020 Q1 -- -- -$0.39 -$0.36 -$0.04
03/13/2020 Q4 -- -- -$0.31 -- --
11/06/2019 Q3 -- -- -$0.24 -- --
08/07/2019 Q2 -- -- -- -- --
05/07/2019 Q1 -- -- -- -- --
03/07/2019 Q4 -- -- -$0.30 -$0.26 -$0.04
11/07/2018 Q3 -- -- -$0.27 -$0.25 -$0.02
08/07/2018 Q2 -- -- -$0.51 -$0.36 -$0.15

Verrica Pharmaceuticals Earnings Questions

  • How Much did Verrica Pharmaceuticals Generate in Revenue Last Quarter?

    Verrica Pharmaceuticals reported $344K worth of top line sales in its most recent quarter.

  • Did Verrica Pharmaceuticals Beat Earnings Last Quarter?

    Verrica Pharmaceuticals announced earnings per share of -$0.24 which represents a beat of analyst forecast a -$0.24 per share.

  • Is Verrica Pharmaceuticals Profitable?

    Verrica Pharmaceuticals reported -$281K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Verrica Pharmaceuticals EPS Next Year?

    Verrica Pharmaceuticals's earnings are forecast to decrease from -$1.48 per share to -$1.40 per share next year representing a decrease of -71.22%.

  • When is Verrica Pharmaceuticals's Earnings Date?

    Verrica Pharmaceuticals's next earnings date is August 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Bloom Energy Stock Go?
How High Will Bloom Energy Stock Go?

Bloom Energy (NYSE:BE) has seen its shares surge by more…

Is Acuity a Good Stock to Buy Now?
Is Acuity a Good Stock to Buy Now?

Acuity Brands (NYSE:AYI) is an industrial company specializing in lighting.…

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 38x

Buy
74
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
49
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
71
NUTX alert for May 15

Nutex Health [NUTX] is up 2.77% over the past day.

Buy
81
EXEL alert for May 15

Exelixis [EXEL] is up 5.26% over the past day.

Sell
29
GLBE alert for May 15

Global E Online [GLBE] is down 4.61% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock